
Eglaf Plus 75mg/10mg/1500mcg Tablet SR
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Overview Eglaf Plus 75mg/10mg/1500mcg Tablet SR
Combiflam SR 75mg/10mg/1500mcg tablets offer relief from neuropathic pain. This combination medication regulates nerve cell calcium channel activity to reduce pain signals. It also boosts brain neurotransmitters, improving mood and safeguarding nerve fibers. Combiflam SR may be taken with or without food, but consistent daily timing ensures stable blood levels. Always follow your doctor's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement. Abrupt cessation may exacerbate symptoms. Common side effects include constipation, weight increase, and dry mouth. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until the medication's effects are known. Weight gain may occur; a balanced diet and regular exercise can help manage this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your physician. Prior to commencing treatment, disclose any kidney or liver conditions, and list all other medications being taken, as interactions may impact efficacy or mechanism. Inform your doctor about pregnancy, pregnancy plans, or breastfeeding.
Uses of Eglaf Plus 75mg/10mg/1500mcg Tablet SR
Managing neuropathic pain
Major Benefits of Eglaf Plus 75mg/10mg/1500mcg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eglaf Plus 75mg/10mg/1500mcg Sustained-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Eglaf Plus 75mg/10mg/1500mcg Tablet SR:
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Difficulty in urination
- Decreased appetite
- Nausea
- Vomiting
- Constipation
- Weight gain
- Dizziness
- Sleepiness
- Tiredness
- Blurred vision
- Dryness in mouth
- Uncoordinated body movements
- Diarrhea
- Headache
How to use Eglaf Plus 75mg/10mg/1500mcg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eglaf Plus 75mg/10mg/1500mcg Extended-Release Tablets may be consumed with or without food, however, consistent timing is recommended.
How Eglaf Plus 75mg/10mg/1500mcg Tablet SR works:
Eglaf Plus 75mg/10mg/1500mcg sustained-release tablets contain pregabalin, nortriptyline, and methylcobalamin. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain by modulating nerve cell calcium influx. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thus inhibiting pain signal transmission in the brain. Methylcobalamin, a vitamin B12 derivative, promotes myelin sheath production and repair, protecting and restoring nerve fibers. This synergistic action provides effective relief from neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Eglaf Plus 75mg/10mg/1500mcg sustained-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The extended-release Eglaf Plus 75mg/10mg/1500mcg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Eglaf Plus 75mg/10mg/1500mcg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Eglaf Plus 75mg/10mg/1500mcg Tablet SR, due to potential side effects that can reduce alertness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Eglaf Plus 75mg/10mg/1500mcg Tablet SR. Dosage modification of Eglaf Plus 75mg/10mg/1500mcg Tablet SR might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Eglaf Plus 75mg/10mg/1500mcg Tablet SR in individuals with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, though further data is limited. Physician consultation is advised.
What if you forget to take Eglaf Plus 75mg/10mg/1500mcg Tablet SR :
Should you forget to take your Eglaf Plus 75mg/10mg/1500mcg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eglaf Plus 75mg/10mg/1500mcg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience Central Nervous System |
